Mostrar el registro sencillo del ítem
dc.contributor.author | Usó Talamantes, Ruth | es_ES |
dc.contributor.author | Caballer Tarazona, María | es_ES |
dc.contributor.author | Buigues Pastor, Laia | es_ES |
dc.contributor.author | Trillo Mata, José Luis | es_ES |
dc.contributor.author | Guadalajara Olmeda, María Natividad | es_ES |
dc.contributor.author | Vivas Consuelo, David José Juan | es_ES |
dc.date.accessioned | 2015-01-19T15:14:18Z | |
dc.date.available | 2015-01-19T15:14:18Z | |
dc.date.issued | 2011-11 | |
dc.identifier.issn | 1098-3015 | |
dc.identifier.uri | http://hdl.handle.net/10251/46185 | |
dc.description | Elsevier user license: Permitted: For non-commercial purposes: Read, print & download Text & data mine Translate the article Not Permitted: Reuse portions or extracts from the article in other works Redistribute or republish the final article Sell or re-use for commercial purposes | es_ES |
dc.description.abstract | The Valencian Community, with 5,000,000 inhabitants, is implementing a system of pharmaceutical management to reduce costs. This system is based on classifying patients in groups using the case mix system, Clinical Risk Groups. An electronic tool has been developed based on www to manage patients with chronic conditions and monitor pharmaceutical expenditure in primary health care. GPs receive a report on the real pharmaceutical cost that is being incurred and the optimum cost adjusted by CRG. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation.ispartof | Value in Health | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject.classification | ECONOMIA APLICADA | es_ES |
dc.subject.classification | ECONOMIA FINANCIERA Y CONTABILIDAD | es_ES |
dc.subject.classification | ECONOMIA, SOCIOLOGIA Y POLITICA AGRARIA | es_ES |
dc.title | Predictability of pharmaceutical spending using Clinical Risk Groups in the Valencian Community, Valencia | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1016/j.jval.2011.08.596 | |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Centro de Ingeniería Económica - Centre d'Enginyeria Econòmica | es_ES |
dc.description.bibliographicCitation | Usó Talamantes, R.; Caballer Tarazona, M.; Buigues Pastor, L.; Trillo Mata, JL.; Guadalajara Olmeda, MN.; Vivas Consuelo, DJJ. (2011). Predictability of pharmaceutical spending using Clinical Risk Groups in the Valencian Community, Valencia. Value in Health. 14(7):A341-A341. doi:10.1016/j.jval.2011.08.596 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.jval.2011.08.596 | es_ES |
dc.description.upvformatpinicio | A341 | es_ES |
dc.description.upvformatpfin | A341 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 14 | es_ES |
dc.description.issue | 7 | es_ES |
dc.relation.senia | 214347 |